STOCK TITAN

LifeVantage (LFVN) insider filing shows PRSU awards, ESPP purchase and insider sale

Filing Impact
(Moderate)
Filing Sentiment
(Negative)
Form Type
4

Rhea-AI Filing Summary

The Form 4 filed for LifeVantage Corp (LFVN) reports insider activity by CFO Carl Aure. On 08/31/2025 Mr. Aure had 14,792 and 18,886 Performance Restricted Stock Units (PRSUs) marked as acquired (codes M) that convert one-for-one into common stock when vesting criteria are met, and the filing notes those PRSUs were originally granted in 2023 and 2024. The report also reflects 718 shares purchased under the Employee Stock Purchase Plan, and a disposition of 16,610 shares sold at $13.10 per share. Following the transactions, the filing shows total beneficial ownership figures reported per line items.

Positive

  • Receipt of PRSUs that convert one-for-one to common stock upon vesting, indicating compensation tied to performance goals
  • Purchase of 718 shares under the Employee Stock Purchase Plan, showing additional insider buy-through-plan activity

Negative

  • Disposition of 16,610 shares sold at $13.10, representing insider selling activity that reduces reported holdings

Insights

TL;DR Insider received performance awards and purchased ESPP shares while also selling a block of 16,610 shares at $13.10.

The filing documents non-derivative and derivative activity for CFO Carl Aure. Material elements are PRSU awards converting one-for-one into common stock when vested, inclusion of an ESPP purchase (718 shares), and a cash disposition of 16,610 shares at $13.10. These are routine compensation-related and personal-trading transactions rather than corporate actions; they change the insider's reported holdings but do not include other material events such as debt changes or M&A developments.

TL;DR Transactions reflect compensation vesting mechanics and ordinary insider trading, requiring disclosure but not indicating corporate governance changes.

The Form 4 shows PRSUs granted in prior years and vesting contingent on time and performance, an ESPP purchase, and a sale of shares. From a governance perspective, these items are standard: they disclose alignment of management incentives with shareholders and individual liquidity actions. The filing includes a power-of-attorney signature and required transaction codes, meeting Form 4 disclosure norms.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Aure Carl

(Last) (First) (Middle)
3300 N. TRIUMPH BLVD
SUITE 700

(Street)
LEHI UT 84043

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Lifevantage Corp [ LFVN ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
Chief Financial Officer
3. Date of Earliest Transaction (Month/Day/Year)
08/31/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 08/31/2025 M 14,792(1) A $0 159,054(2) D
Common Stock 08/31/2025 M 18,886(3) A $0 177,940 D
Common Stock 08/31/2025 F 16,610 D $13.1 161,330 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Performance Restricted Stock Units (4) 08/31/2025 M 14,792 (1) (1) Common Stock 14,792 $0 4,931 D
Performance Restricted Stock Units (4) 08/31/2025 M 18,886 (3) (3) Common Stock 18,886 $0 9,443 D
Explanation of Responses:
1. On August 24, 2023, the reporting person was granted Performance Restricted Stock Units ("PRSUs") which vest upon achievement of previously established time-based and financial performance criteria.
2. Includes 718 total shares purchased on August 31, 2025 under the Employee Stock Purchase Plan.
3. On August 26, 2024, the reporting person was granted PRSUs which vest upon achievement of previously established time-based and financial performance criteria.
4. PRSUs convert into common stock on a one-for-one basis.
Remarks:
/s/ Alissa Neufeld, Power of Attorney for Carl Aure 09/03/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What transactions did LFVN CFO Carl Aure report on Form 4?

The filing reports conversion-eligible PRSUs (14,792 and 18,886 units), an ESPP purchase of 718 shares, and a sale of 16,610 shares at $13.10.

Do the PRSUs reported for LFVN immediately create shares?

No. The document states PRSUs convert one-for-one into common stock when previously established time-based and financial performance criteria are met.

When were the PRSUs originally granted according to the filing?

The filing notes PRSUs were granted on August 24, 2023 and August 26, 2024.

How many shares did Carl Aure own after the reported transactions?

The Form 4 lists resulting beneficial ownership amounts per transaction line (examples include 159,054, 177,940, and 161,330 as reported following transactions).

Was the Form 4 signed by the reporting person?

The filing shows it was signed by Alissa Neufeld, Power of Attorney for Carl Aure on 09/03/2025.
Lifevantage Corp

NASDAQ:LFVN

LFVN Rankings

LFVN Latest News

LFVN Latest SEC Filings

LFVN Stock Data

77.10M
10.48M
16.79%
65.65%
19.95%
Packaged Foods
Pharmaceutical Preparations
Link
United States
LEHI